Pricing

Forma Therapeutics Holdings, Inc. (FMTX)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Frank D. Lee
Employees:
170
300 NORTH BEACON STREET, SUITE 501, WATERTOWN, MA, 02472
617-679-1970
Forma Therapeutics Holdings, Inc. focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available